Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

LEV Proteomics Reveals Monocyte-Derived RETN as a Driver of Diabetic Retinopathy Progression

ABSTRACT: To characterize proteomic alterations in plasma and plasma-derived exosomes across different stages of diabetic retinopathy (DR) and identify exosome-associated proteins involved in disease progression.

ORGANISM(S): Homo Sapiens

SUBMITTER: Xiaorong Li

PROVIDER: PXD079737 | iProX | Mon Jun 15 00:00:00 GMT+01:00 2026

REPOSITORIES: iProX

ACCESS DATA

Json Xml

Similar Datasets

Plasma Proteomics Reveals Monocyte-Derived RETN as a Driver of Diabetic Retinopathy Progression

Project description:To characterize proteomic alterations in plasma and plasma-derived exosomes across different stages of diabetic retinopathy (DR) and identify exosome-associated proteins involved in disease progression.

2026-06-12 | PXD079615 |

Integrated Exosomal Proteomics Reveals Monocyte-Derived Exosomal RETN as a Driver of Diabetic Retinopathy Progression

2026-06-11 | PXD079568 |

Association between lncRNAs in plasma exosomes and diabetic retinopathy

Project description:Long noncoding RNA (lncRNA) in plasma exosomes is a potential non-invasive diagnostic biomarker for diabetic retinopathy (DR). However, the changes in plasma exosomal lncRNAs and diagnostic relevance in patients with DR patients remain unclear. A case–control study with type 2 diabetes mellitus (T2DM) and patients with comorbid DR were enrolled, and their clinical information and blood samples were collected.

2022-09-06 | GSE212594 | GEO

Influence of diabetic retinopathy on peripheral blood gene expression

Project description:To understand the association between systemic factors and the diabetic retinopathy, blood samples were collected in 50 healthy controls, 74 diabetic patients without diabetic retinopathy (DM group), and 69 diabetic retinopathy (DR Group). T1DM and T2DM in this study was based on the diagnostic criteria for diabetes proposed by the WHO in 1999. The diagnosis of DR was based on the international clinical classification of DR proposed at the 2002 International Ophthalmology Conference. We then performed gene expression profiling analysis using data obtained from RNA-seq of three patient groups.

2023-05-26 | GSE221521 | GEO

ETS1 Downregulation Regulated by a Novel miRNA: Insights into the Anti-Angiogenic Shift in Non-Proliferative Diabetic Retinopathy

Project description:Non-proliferative Diabetic retinopathy (NPDR) is the early stage of diabetic retinopathy, which features the imbalance between anti-angiogenic and pro-angiogenic factors. The exact regulatory mechanism is still unclear. In this study, we aimed to unravel novel insights into the regulatory mechanisms underlying the endothelial dysfunction in NPDR by investigating the newly discovered miRNAs that enriched in the plasma of DR.

2025-06-11 | GSE269716 | GEO

Putative tear fluid biomarkers of diabetic retinopathy

Project description:Identification of tear fluid biomarkers may offer a non-invasive strategy for detecting diabetic patients with increased risk of developing diabetic retinopathy (DR) or increased disease progression, thus helping both improving diagnostic accuracy and understanding the pathophysiology of the disease. The goal of this study was to characterize the proteomic profile of human tear fluid and examine changes in proteins expression in different stages of diabetic retinopathy.

2022-05-31 | PXD033101 | Pride

A single cell atlas of circulating immune cells involved in diabetic retinopathy

Project description:Circulating immune cells play a role in the pathophysiology of diabetic retinopathy (DR). Our study focused on examining the exact role of circulating immune cells in the development of DR. Single-cell RNA sequencing (scRNA-seq) techniques revealed unique differentially-expressed genes and pathways in circulating immune cells among non-diabetic retinopathy (NDR) patients and DR patients. These findings highlight the notable alterations in the immunophenotypes of circulating immune cells in patients with type 1 DR.

2024-02-14 | GSE248284 | GEO

Extracellular vesicles of human diabetic retinopathy retinal tissue and urine of diabetic retinopathy patients analyzed using mass spectrometry

Project description:Diabetic Retinopathy (DR) is a potentially blinding retinal disorder which develops through the pathogenesis of diabetes. Extracellular Vesicles (EVs) provide a novel biomarker for pre-symptomatic disease diagnosis and prognosis. Proteomic analysis was performed on explanted DR retinal tissue, DR retinal EVs and DR urinary EVs. DR samples were compared to normal retinal tissue, retinal EVs and urinary EVs, respectively

2022-12-31 | PXD034626 | Pride

Identification of plasma exosomal protein markers associated with diabetic retinopathy progression by proteomic analysis

Project description:Protein biomarkers derived from plasma exosome have been extensively identified in various diseases. This study aimed to explore the biomarkers at different stages of diabetes retinopathy (DR) progression. Two cohorts, discovery and validation cohorts, were included in this study. The discovery cohort was used for proteomic analysis to screen differentially expressed proteins (DEPs). Hub proteins were identified by Wilcox.test, and their correlation with clinical characteristics were further analyzed. The validation cohort was used for enzyme-linked immunosorbent assay (ELISA) to verify the expression of hub proteins. Receiver operator characteristic (ROC) curve was conducted to evaluate the diagnostic values of hub proteins for DR progression. The correlation with clinical indicators was further analyzed.

2025-06-11 | PXD064059 | Pride

Role of Circulating Exosomal miRNAs in early diabetic retinopathy

Project description:To investigate the possibilities of circulating exosomal miRNAs in the early screening and prevention of diabetic retinopathy(DR), and to explore how the exosomal miRNAs functioning in DR. We then performed gene expression profiling analysis using data obtained from small RNA-seq of 3 diabetes mellitus(DM) patients and 3 DR patients.

2023-07-12 | GSE221535 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data